MANNKIND CORP(NASDAQ:MNKD) stock News

MNKD Latest News, Press Relases and Analysis

All

Press Releases

3 days ago - By: Yahoo Finance

MannKind Corporation (MNKD) Seeks FDA Pediatric Approval for Afrezza

4 days ago - By: Brodsky & Smith LLC - Mentions: SCPH VTLE IMXI HBI ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: scPharmaceuticals Inc. (Nasdaq – SCPH), Vital Energy, Inc. (NYSE – VTLE), International Money Express, Inc. (Nasdaq - IMXI), HanesBrands Financial Corp. (NYSE - HBI)

5 days ago - By: MannKind

MannKind to Present at Upcoming Investor Conferences

5 days ago - By: Zacks Investment Research - Mentions: CVGI INBK

New Strong Sell Stocks for August 27th

5 days ago - By: MannKind

MannKind to Present at Upcoming Investor Conferences

5 days ago - By: MannKind

MannKind Announces Expansion of United Therapeutics Collaboration for Second Inhaled Therapy

5 days ago - By: MannKind

MannKind Announces Expansion of United Therapeutics Collaboration for Second Inhaled Therapy

a month ago - By: Benzinga - Mentions: OEC VTLE DIN INSE ...

Earnings Scheduled For August 6, 2025

a month ago - By: Benzinga

A Look Ahead: MannKind's Earnings Forecast

7 days ago - By: MannKind

MannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a Patient-Centric Leader in Cardiometabolic and Lung Diseases

7 days ago - By: MannKind - Mentions: SCPH

MannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a Patient-Centric Leader in Cardiometabolic and Lung Diseases

10 days ago - By: Yahoo Finance

Leerink Partners Reiterates a Buy on MannKind Corporation (MNKD), Keeps the PT

15 days ago - By: Yahoo Finance

MannKind (MNKD) Secures $500M Financing to Advance Inhaled Therapies Pipeline

a month ago - By: The Motley Fool

MannKind (MNKD) Q2 Revenue Rises 6%

a month ago - By: Zacks Investment Research

MannKind (MNKD) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

a month ago - By: Zacks Investment Research - Mentions: PHAT

MannKind (MNKD) Reports Break-Even Earnings for Q2

a month ago - By: MannKind

MannKind and Blackstone Announce up to $500 Million Strategic Financing Agreement

a month ago - By: MannKind

MannKind and Blackstone Announce up to $500 Million Strategic Financing Agreement

a month ago - By: MannKind

MannKind Corporation Reports Second Quarter 2025 Financial Results And Provides Business Update

a month ago - By: MannKind

MannKind Corporation Reports Second Quarter 2025 Financial Results And Provides Business Update

a month ago - By: MannKind

MannKind Corporation to Hold 2025 Second Quarter Financial Results Conference Call on August 6, 2025

a month ago - By: MannKind

MannKind Corporation to Hold 2025 Second Quarter Financial Results Conference Call on August 6, 2025

2 months ago - By: Yahoo Finance - Mentions: WFC

Wells Fargo Maintains a Buy Rating on MannKind Corporation (MNKD), Sets a $9 PT

2 months ago - By: Yahoo Finance

Leerink Partners Slashes MannKind Corporation’s (MNKD) Price Target to $7, Keeps a Buy Rating

2 months ago - By: Yahoo Finance

MannKind (MNKD) Presents Pediatric Insulin Trial Data

3 months ago - By: MannKind

MannKind to Highlight Data from Recent Pediatric and Adult Studies of Inhaled Insulin (Afrezza®) at American Diabetes Association’s 85th Scientific Sessions in Chicago, June 20-23

3 months ago - By: MannKind

MannKind to Highlight Data from Recent Pediatric and Adult Studies of Inhaled Insulin (Afrezza®) at American Diabetes Association’s 85th Scientific Sessions in Chicago, June 20-23

3 months ago - By: MannKind

INDYCAR Driver Conor Daly To Share His Personal Diabetes Story and Race Go-Karts With Detroit Area Youth On Thursday, May 29

4 months ago - By: MannKind

MannKind to Present at Upcoming Investor Conferences

4 months ago - By: Yahoo Finance - Mentions: UNP POOL

MannKind Corporation (MNKD): Among the Best Cancer Stocks to Invest in for Long-Term Gain

4 months ago - By: Zacks Investment Research - Mentions: AGEN

MannKind (MNKD) Beats Q1 Earnings and Revenue Estimates

4 months ago - By: MannKind

MANNKIND CORP (MNKD) Stock News

MNKD Latest News, Press Relases and Analysis

MannKind Corporation (MNKD) Seeks FDA Pediatric Approval for Afrezza

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: scPharmaceuticals Inc. (Nasdaq – SCPH), Vital Energy, Inc. (NYSE – VTLE), International Money Express, Inc. (Nasdaq - IMXI), HanesBrands Financial Corp. (NYSE - HBI)

MannKind to Present at Upcoming Investor Conferences

New Strong Sell Stocks for August 27th

MannKind to Present at Upcoming Investor Conferences

MannKind Announces Expansion of United Therapeutics Collaboration for Second Inhaled Therapy

MannKind Announces Expansion of United Therapeutics Collaboration for Second Inhaled Therapy

Earnings Scheduled For August 6, 2025

A Look Ahead: MannKind's Earnings Forecast

MannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a Patient-Centric Leader in Cardiometabolic and Lung Diseases

MannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a Patient-Centric Leader in Cardiometabolic and Lung Diseases

Leerink Partners Reiterates a Buy on MannKind Corporation (MNKD), Keeps the PT

MannKind (MNKD) Secures $500M Financing to Advance Inhaled Therapies Pipeline

MannKind (MNKD) Q2 Revenue Rises 6%

MannKind (MNKD) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

MannKind (MNKD) Reports Break-Even Earnings for Q2

MannKind and Blackstone Announce up to $500 Million Strategic Financing Agreement

MannKind and Blackstone Announce up to $500 Million Strategic Financing Agreement

MannKind Corporation Reports Second Quarter 2025 Financial Results And Provides Business Update

MannKind Corporation Reports Second Quarter 2025 Financial Results And Provides Business Update

MannKind Corporation to Hold 2025 Second Quarter Financial Results Conference Call on August 6, 2025

MannKind Corporation to Hold 2025 Second Quarter Financial Results Conference Call on August 6, 2025

Wells Fargo Maintains a Buy Rating on MannKind Corporation (MNKD), Sets a $9 PT

Leerink Partners Slashes MannKind Corporation’s (MNKD) Price Target to $7, Keeps a Buy Rating

MannKind (MNKD) Presents Pediatric Insulin Trial Data

MannKind to Highlight Data from Recent Pediatric and Adult Studies of Inhaled Insulin (Afrezza®) at American Diabetes Association’s 85th Scientific Sessions in Chicago, June 20-23

MannKind to Highlight Data from Recent Pediatric and Adult Studies of Inhaled Insulin (Afrezza®) at American Diabetes Association’s 85th Scientific Sessions in Chicago, June 20-23

INDYCAR Driver Conor Daly To Share His Personal Diabetes Story and Race Go-Karts With Detroit Area Youth On Thursday, May 29

MannKind to Present at Upcoming Investor Conferences

MannKind Corporation (MNKD): Among the Best Cancer Stocks to Invest in for Long-Term Gain

MannKind (MNKD) Beats Q1 Earnings and Revenue Estimates

MannKind Corporation Reports First Quarter 2025 Financial Results and Provides Business Update